The Weight of Success: Why Breakthrough Obesity Drugs Are a Budget Breaker

Trump's Biotech Revolution: Unleashing a Staggering $350 Billion Investment Wave

Global Health Titans Act: FDA Tightens Grip on Safe Weight-Loss Meds as WHO Elevates Them to Essential Status

A New Horizon in Lung Cancer Treatment: FDA Grants Breakthrough Status to Lilly-Merck Combination Therapy

Wegovy Triumphs: Novo Nordisk's Obesity Drug Significantly Cuts Heart Attack and Stroke Risk, Setting a New Benchmark in Cardiovascular Protection

Prothena's PRX012 Alzheimer's Drug Shines with 'Non-Competitive' Brain Swelling Rates, Offering New Hope

UK Healthcare on Edge: Mounjaro Shortages Loom as Eli Lilly's Price Hike Sparks Patient Panic

The Weighty Truth: Are Next-Gen Obesity Drugs Worth Their Premium Price Tag?

Viking Therapeutics' Oral Weight Loss Drug Stumbles: VK2735 Data Leaves Investors Underwhelmed